Skip to content
DraconiticResearch
Search Sources API
203,952 studies31 sourcesUpdated 9 min ago

Oncology

5,176 studies502 in 7 days2,477 in 30 days

Filters
Type
Date
Clear

Latest

5,176 studies

  1. Squalene as a Candidate Signalling Molecule: Computational Evidence for a Predicted KEAP1 Interaction and Implications for Stress-Induced Altruistic Stem-Cell Niche Protection
    P. Dutta, U. Sarmah, L. Pathak +4
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  2. Optimization of a Subcutaneous Epithelioid Hemangioendothelioma Xenograft Model for Evaluation of Preclinical Therapeutics
    Z. Chen, L. Wang, V. Zuco +5
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  3. Early Progression Cells mark a stem-like state associated with pancreatic cancer initiation and progression
    B. Salvador-Barbero, E. K. Reed, D. Ruiz-Palacios +6
    bioRxivPreprintCC BYFull textOncologybioRxiv
  4. The Clinical and Cellular Landscape of DKK1 in Osteosarcoma
    E. Uceda Arias-Stella, L. Kastner, N. Copperman +11
    medRxivPreprintCC BY-NCFull textOncologymedRxiv
  5. Sitagliptin, a repurposed diabetes drug, overcomes gemcitabine resistance in pancreatic cancer via ribonucleotide reductase inhibition: SITGEM-CARE phase 2 trial.
    Jun Yu, Shangheng Shi, Mengyu Li +31
    Signal transduction and targeted therapyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  6. Plasma IFNL3 for Gastric Cancer Detection and Monitoring in East Asians: A Multiphase Study
    Yunmeng Nie, Jihong Zhong, Siyi Ni +3
    Cancer MedicinePeer-reviewedCC BY-NC-ND 4.0Full textOncologyDOAJPMC
  7. MET inhibition exploits conserved regulatory dependencies in malignant rhabdoid tumors
    I. Sentis, A. Cebria-Xart, Q. Rovira +23
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  8. Glioblastoma model mouse rescue from mortality by brain-targeted catalytically-enhanced angiotensin-converting enzyme 2 mutant-antibody fusion protein
    P. Heinzelman, G. R. Nageeb, J. Choi +4
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  9. The Pregnane X Receptor (PXR) contributes to phenotypic plasticity and modulates the sensitivity to targeted therapies in melanoma
    S. D. Nicolescu, A. Matheux, M. Grimaldi +15
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  10. Lineage tracing in rhabdoid tumor organoids and orthotopic xenografts reveals convergent transcriptional states
    G. Perticari, J. DeMartino, A. Fumagalli +6
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  11. ASSESSMENT OF TREATMENT RESPONSE RESPONSE AND THE ROLE OF COMPLETION SURGERY AFTER CONCURRENT CRTAND BRACHYTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER - A REVIEW FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP
    Camille Mimoun, Xavier Carcopino, Lobna Ouldamer +40
    Journal of Gynecology Obstetrics and Human ReproductionPeer-reviewedCC BYFull textOncologyHAL
  12. POST-TREATMENT SURVEILLANCE AND MANAGEMENT OF RECURRENT CERVICAL CANCER - A REVIEW FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP
    Aurélie Buffeteau, Abel Cordoba, Jean Levêque +45
    Journal of Gynecology Obstetrics and Human ReproductionPeer-reviewedCC BYFull textOncologyHAL
  13. FERTILITY-SPARING SURGERY AND OVARIAN TRANSPOSITION IN CERVICAL CANCER - A REVIEW FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP
    François Margueritte, Patrice Mathevet, Caroline Diguisto +43
    Journal of Gynecology Obstetrics and Human ReproductionPeer-reviewedLicence not statedFull textOncologyHAL
  14. CERVICAL CANCER: NATIONAL CLINICAL PRACTICE GUIDELINES FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP
    Xavier Carcopino, Lobna Ouldamer, Cyrille Huchon +39
    Journal of Gynecology Obstetrics and Human ReproductionPeer-reviewedCC BYOncologyHAL
  15. The long road after breast cancer: survivorship issues and long-term treatment effects in young women
    Martina Pagliuca, Roberto Buonaiuto, Annarita Verrazzo +15
    Frontiers in OncologyPeer-reviewedCC BYFull text1 citedOncologyHAL
  16. Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial
    Susanne A. Gatz, Pablo Berlanga, Gwénaël Le Teuff +36
    Clinical Cancer ResearchPeer-reviewedLicence not stated4 citedOncologyHAL
  17. Variation in recommendations for management of pediatric fever and neutropenia across databases and languages: A systematic review of clinical practice guidelines
    Asher Hancock, Brandon Fickling, Tea Reljic +4
    PLOS OnePeer-reviewedCC BY 4.0Full textInfectious diseaseOncologyObstetrics, gynaecology & paediatricsPLOSPMC
  18. PIVKA-II and hematological parameters in hepatocellular carcinoma and non-malignant chronic liver disease: A case-control biomarker comparison in a hepatitis-endemic population
    Muhammad Sameer Hashmi, Muhammad Aqif Ilyas
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOSPMC
  19. Sex difference in survival benefits of immune checkpoint inhibitors in advanced non-small cell lung cancer: A meta-analysis
    Tingting Liu, Dandan Song, Jun Chen +3
    PLOS OnePeer-reviewedCC BY 4.0Full textClinical trials & evidence synthesisEpidemiology & public healthOncologyPLOSPMC
  20. Rigorous nested cross-validation and external generalization-gap analysis of a machine-learning classifier for U-251 glioblastoma cytotoxicity
    Yuki Uemichi, Shuhei Nakao, Shuji Nagano +4
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPharmacology & toxicologyPhysiologyPLOSPMC
  21. Comparative Age-Period-Cohort Analysis Reveals Divergent Temporal Trajectories of Breast and Colorectal Cancer Among Women in Singapore
    Josephine Yi Hui Pan, Mengyu Li, Dawn Qingqing Chong +5
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  22. Elevated Allele Frequency of a Common Germline PDCD1 Variant Associated with Leukocytosis and Thrombocytopenia in Acute Myeloid Leukemia Treated with HDCT/ASCT
    Katja Seipel, Ranja Leuenberger, Henning Nilius +5
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  23. Survival and Extent of Breast Surgery in Patients with Complete Response After Neoadjuvant Therapy: A Retrospective Analysis from the EUSOMA Database
    Federica Martorana, Damiano Gentile, Mariano Tomatis +14
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  24. Trends and Patterns in Gastrointestinal Cancer Burden in Asia, 1990–2023: Evidence from the Global Burden of Disease Study 2023
    Lanwei Guo, Chenxin Zhu, Jiani Yuan +5
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  25. Proton-Induced Bystander Signaling Drives Cell-Type-Specific Proteomic Remodeling in Chondrocytes and Endothelial Cells
    Mihaela Tudor, Benoît Bernay, Mihaela Temelie +3
    CancersPeer-reviewedCC BY 4.0OncologyCrossref